Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$265.58-0.77 (-0.29%)
Delayed quote: Sep 11, 2026, 4:00 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 11, 2026, 4:00 PM EDT
Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 13.89% is in line with its 5-year average of 14.33%, around the middle of its 5-year range (12.01%–16.61%).
As of the fiscal period ended Sunday, June 28, 2026. 4.50% above its 12-month average of 13.29%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-28): 13.89%.
RETURN ON INVESTED CAPITAL (ROIC)
13.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
13.29%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
14.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
14.33%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
14.20%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
14.08%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
14.90%
CURRENT VS TTM AVG
+4.50%
CURRENT VS 3Y AVG
-0.85%
CURRENT VS 5Y AVG
-3.07%
CURRENT VS 10Y AVG
-2.20%
CURRENT VS 15Y AVG
-1.38%
CURRENT VS 20Y AVG
-6.82%
SECTOR MEDIAN · HEALTHCARE
8.75%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+58.80%
vs the sector median at left
Johnson & Johnson
Market Cap
$640.02B
Return on Invested Capital (ROIC)
13.89%
TTM Avg
13.29%
3Y Avg
14.01%
5Y Avg
14.33%
Market Cap
$157.99B
Return on Invested Capital (ROIC)
9.33%
TTM Avg
9.06%
3Y Avg
10.61%
5Y Avg
10.43%
Market Cap
$355.49B
Return on Invested Capital (ROIC)
5.80%
TTM Avg
18.65%
3Y Avg
14.46%
5Y Avg
12.98%
Market Cap
$454.17B
Return on Invested Capital (ROIC)
13.46%
TTM Avg
10.91%
3Y Avg
11.35%
5Y Avg
11.16%
Market Cap
$1.05T
Return on Invested Capital (ROIC)
27.38%
TTM Avg
28.28%
3Y Avg
24.95%
5Y Avg
23.04%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Johnson & Johnson (JNJ) | $640.02B | 13.89% | 13.29% | 14.01% | 14.33% |
| Pfizer Inc. (PFE)vs › | $157.99B | 9.33% | 9.06% | 10.61% | 10.43% |
| Merck & Co., Inc. (MRK)vs › | $355.49B | 5.80% | 18.65% | 14.46% | 12.98% |
| AbbVie Inc. (ABBV)vs › | $454.17B | 13.46% | 10.91% | 11.35% | 11.16% |
| Eli Lilly and Company (LLY)vs › | $1.05T | 27.38% | 28.28% | 24.95% | 23.04% |
| Bristol-Myers Squibb Company (BMY)vs › | $130.00B | 15.47% | 14.35% | 12.24% | 10.38% |
ROIC
13.9%
ROE
24.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-28 | 13.89% |
| 2026-03-29 | 13.60% |
| 2025-12-28 | 13.82% |
| 2025-09-28 | 12.93% |
| 2025-06-29 | 12.22% |
| 2025-03-30 | 12.01% |
| 2024-12-29 | 13.69% |
| 2024-09-29 | 14.59% |
| 2024-06-30 | 14.55% |
| 2024-03-31 | 15.13% |
| 2023-12-31 | 16.61% |
| 2023-10-01 | 15.93% |
| 2023-07-02 | 13.13% |
| 2023-04-02 | 12.66% |
| 2022-12-31 | 12.96% |
| 2022-10-02 | 14.85% |
| 2022-07-03 | 15.71% |
| 2022-04-03 | 15.99% |
| 2021-12-31 | 16.01% |
| 2021-10-03 | 15.98% |
| 2021-07-04 | 14.60% |
| 2021-04-04 | 13.58% |
| 2020-12-31 | 13.29% |
| 2020-09-27 | 13.20% |
| 2020-06-28 | 14.84% |
| 2020-03-29 | 15.38% |
| 2019-12-31 | 14.88% |
| 2019-09-29 | 14.82% |
| 2019-06-30 | 14.15% |
| 2019-03-31 | 14.68% |
| 2018-12-31 | 14.45% |
| 2018-09-30 | 8.56% |
| 2018-07-01 | 8.11% |
| 2018-04-01 | 7.96% |
| 2017-12-31 | 7.97% |
| 2017-10-01 | 12.47% |
| 2017-07-02 | 13.09% |
| 2017-04-02 | 13.94% |
| 2016-12-31 | 14.78% |
| 2016-10-02 | 13.69% |
| 2016-07-03 | 13.29% |
| 2016-04-03 | 12.90% |
| 2015-12-31 | 13.03% |
| 2015-09-27 | 13.45% |
| 2015-06-28 | 13.57% |
| 2015-03-29 | 14.72% |
| 2014-12-31 | 15.40% |
| 2014-09-28 | 16.07% |
| 2014-06-29 | 15.97% |
| 2014-03-30 | 15.69% |
| 2013-12-31 | 15.15% |
| 2013-09-29 | 14.11% |
| 2013-06-30 | 13.43% |
| 2013-03-31 | 13.08% |
| 2012-12-31 | 12.77% |
| 2012-09-30 | 12.40% |
| 2012-07-01 | 12.70% |
| 2012-04-01 | 12.45% |
| 2011-12-31 | 12.96% |
| 2011-10-02 | 13.63% |
| 2011-07-03 | 13.76% |
| 2011-04-03 | 14.28% |
| 2010-12-31 | 14.87% |
| 2010-10-03 | 15.46% |
| 2010-07-04 | 16.53% |
| 2010-04-04 | 16.23% |
| 2009-12-31 | 16.37% |
| 2009-09-27 | 16.52% |
| 2009-06-28 | 16.85% |
| 2009-03-29 | 17.31% |
| 2008-12-31 | 18.20% |
| 2008-09-28 | 18.29% |
| 2008-06-29 | 18.17% |
| 2008-03-30 | 18.65% |
| 2007-12-31 | 19.05% |
| 2007-09-30 | 18.16% |
| 2007-07-01 | 18.32% |
| 2007-04-01 | 18.46% |
| 2006-12-31 | 18.56% |
| 2006-10-01 | 20.35% |
| 2006-07-02 | 19.75% |
| 2006-04-02 | 19.73% |
| 2005-12-31 | 21.17% |
| 2005-10-02 | 20.41% |
| 2005-07-03 | 21.03% |
| 2005-04-03 | 21.15% |
| 2004-12-31 | 21.49% |
| 2004-09-26 | 22.39% |
| 2004-06-27 | 22.41% |
| 2004-03-28 | 21.60% |
| 2003-12-31 | 21.11% |
| 2003-09-28 | 20.49% |
| 2003-06-29 | 19.81% |